Menu Search Account

LegiStorm

Get LegiStorm App Visit Product Demo Website
» Get LegiStorm App
» Get LegiStorm Pro Free Demo

GAO Reports by subject "Chemotherapy"

Full-text search of 52,071 reports from the Government Accountability Office
From To
Reset

Search Results:

Date Report No. Title
Date Dec. 1, 2004 Report No. GAO-05-142R Title

Medicare Chemotherapy Payments: New Drug and Administration Fees Are Closer to Providers' Costs

United States Government Accountability Office Washington, DC 20548 December 1, 2004 The Honorable Joe Barton Chairman Committee on Energy and Commerce House of Representatives Subject: Medicare Chemotherapy Payments: New Drug and Administration Fees Are Closer to Providers’ Costs Dear Mr. Chairman: The Medicare Prescription Drug, Improvement, and Modernization Act of 2003 1 (MMA) required the S...
Date Oct. 31, 2001 Report No. GAO-02-53 Title

Medicare Physician Fee Schedule: Practice Expense Payments to Oncologists Indicate Need For Overall Refinements

United States General Accounting Office GAO October 2001 Report to Congressional Committees MEDICARE PHYSICIAN FEE SCHEDULE Practice Expense Payments to Oncologists Indicate Need For Overall Refinements Headings for Appendix II and III corrected on 05/03/04. Printed copies of this report were correct. GAO-02-53 a Contents Letter Results in Brief Background Oncology Fares As Well As the Average Spe...
Date Sept. 21, 2001 Report No. GAO-01-1118 Title

Medicare: Payments for Covered Outpatient Drugs Exceed Providers' Costs

United States General Accounting Office GAO September 2001 Report to Congressional Committees MEDICARE Payments for Covered Outpatient Drugs Exceed Providers’ Cost GAO-01-1118 Contents Letter Results in Brief Background Physicians Can Obtain Drugs Covered Under Part B for Significantly Less Than Medicare Payments Medicare Drug Payments Also Substantially Higher Than Costs for Pharmacy Supplier-B...
Date Sept. 21, 2001 Report No. GAO-01-1142T Title

Medicare Part B Drugs: Program Payments Should Reflect Market Prices

United States General Accounting Office GAO Testimony Before the Subcommittee on Health and the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives For Release on Delivery Expected at 9:30 a.m. Friday, September 21, 2001 MEDICARE PART B DRUGS Program Payments Should Reflect Market Prices Statement of William J. Scanlon Director, Health Care Issu...
Date Nov. 16, 1998 Report No. HEHS-99-16R Title

Medicare: Coverage of Pumps Used to Administer Intravenous Drugs

GAO United States General Accounting Office Washington, D.C. 20548 Health, Education, and Human Services Division B-279966 November 16, 1998 The Honorable William M. Thomas Chairman, Subcommittee on Health Committee on Ways and Means House of Representatives The Honorable Philip M. Crane House of Representatives Subject: Medicare: Coverage of Pumas Used to Administer Intravenous Drugs Medicare’ ...
Date April 24, 1996 Report No. HEHS-96-83 Title

Health Insurance: Coverage of Autologous Bone Marrow Transplantation for Breast Cancer

United States General Accounting Office GAO April 1996 Report to the Honorable Ron Wyden, U.S. Senate HEALTH INSURANCE Coverage of Autologous Bone Marrow Transplantation for Breast Cancer G A O years 1921 - 1996 GAO/HEHS-96-83 GAO United States General Accounting Office Washington, D.C. 20548 Health, Education, and Human Services Division B-260550 April 24, 1996 The Honorable Ron Wyden United Stat...
Date Sept. 13, 1995 Report No. HEHS-95-141 Title

Cancer Drug Research: Contrary to Allegation, NIH Hydrazine Sulfate Studies Were Not Flawed

United States General Accounting Office GAO September 1995 Report to the Chairman and Ranking Minority Member, Human Resources and Intergovernmental Relations Subcommittee, House Committee on Government Reform and Oversight CANCER DRUG RESEARCH Contrary to Allegation, NIH Hydrazine Sulfate Studies Were Not Flawed GAO/HEHS-95-141 GAO United States General Accounting Office Washington, D.C. 20548 He...
Date July 17, 1992 Report No. PEMD-92-28 Title

Medicare: Reimbursement Policies Can Influence the Setting and Cost of Chemotherapy

.‘ *“I ...J : A0 . “*-“. .-~-_I~ ...” .--. “. _.II vltdy l!l!U MEDICARE Reimbursement Policies Can Influence the Setting and Cost of Chemotherapy RESTRICTED--Not to be released outside the Y General Accounting Office unless specifically approved by the Office of Congressional Relations. United States General Accounting Of’ flce Washington, D.C. 20648 Program Evaluation and Methodolog...
Date Sept. 27, 1991 Report No. PEMD-91-14 Title

Off-Label Drugs: Reimbursement Policies Constrain Physicians in Their Choice of Cancer Therapies

Reimbursement Policies Constrain Physicians in Their Choice of Cancer Therapies GAO,‘ I~:MI)-9 I’ 1- I4 Program Evaluation and Methodology Division B-24286 1 September 27,lQQl The Honorable Edward M. Kennedy Chairman, Committee on Labor and Human Resources United States Senate Dear Mr. Chairman: At your request, we have studied the prevalence of off-label use of anticancer drugs; how that use ...
Date Feb. 28, 1989 Report No. PEMD-89-9 Title

Breast Cancer: Patients' Survival

GAO February 1989 Report to the Chairman, Subcommittee on-* Health and the Environment, Committee on Energy and Commerce, House of Representatives - BREAST C..NCER Patients’ Survival GAO/PEMD-89-9 About Our New Cover... GAO'S efforts The new color of our report covers represents the latest step in to improve the presentation of our reports. Program Evaluation and Methodology Division B-226468 Fe...
Date Jan. 25, 1988 Report No. PEMD-88-12BR Title

Cancer Treatment 1975-85: The Use of Breakthrough Treatments for Seven Types of Cancer

e on H&&h and the’,, Environment, Committee on Energy and Commerce,House of RepresentativesI ;: _/.. January 1988 CANCER TREATMENT 197&@:- :, . *’ Program Evaluation and Methodology Division B-226468 January 25, 1988 The Bonorable Henry A. Yaxman Chairman, Subcommittee on Health and the Environment Committee on Energy and Commerce !-louse of Representatives Dear Mr. Chairman: One reason often ...
Date March 31, 1987 Report No. PEMD-87-13 Title

Cancer Patient Survival: What Progress Has Been Made?

*# -*-*4”mI,o-LIImI,--I* m---w- United ----- sljxtes Geueral Accounting --_--1-.-s-- O!fici GAO 0: Report xo the Chairman, Subcominkteeon I;rtte:~governmental IRelationsand Human 13esouxes, Committee on Goverrument Operations, Houseof Representatives CANCER F’ATIENT SURVIVAL What P’rogressHas &en Made? 132697 1 IIII II 1111111 IllIll B-m __- - I_ -(t-_l_---L-_(- iG/PEMD-87-13 , ,,, ,,,, ,,,,...
Date Feb. 7, 1979 Report No. HRD-79-42 Title

Health: Federal Hospitals Could Improve Certain Cancer Treatment Capability by Sharing

REPORTB’Y’ THE- Comptroller General OF THE UNITEDSTATES Federal Hospitals Could Improve Certain Cancer Treatment Capability By Sharing The Chairman, House Committee on Appropriations asked GAO to review how the Department of Defense, the Veterans Administration, and the Public Health Service provide cancer care. The three agencies provide such treatment at nearly 300 Federal hospitals. About 6...